Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 52.64
-0.54 (-1.02%)
At close: Feb 13, 2026
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 6.85 billion as of February 13, 2026. Its market cap has increased by 64.56% in one year.
Market Cap
6.85B
Enterprise Value
5.53B
Revenue
352.91M
Ranking
n/a
PE Ratio
143.71
Stock Price
52.64
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 6.85B, a decrease of -34.38%. That is a compound annual growth rate of -11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.85B | 22.73% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Fengbei Biotech Stock | 7.92B |
| Wuhan Keqian Biology Co.,Ltd | 7.65B |
| R&G PharmaStudies | 7.45B |
| GemPharmatech | 7.21B |
| Jiangsu Aidea Pharmaceutical Group | 7.07B |
| Beijing Konruns Pharmaceutical | 6.80B |
| Shenzhen Weiguang Biological Products | 6.51B |
| PharmaResources (Shanghai) | 6.35B |